Inventor · disambiguated record
Steven Fletcher
Also filed as: FLETCHER STEVEN
13 granted patents·10 pending applications·27 citations·filing 2002–2025
86Inventor score
Files withUNIV MARYLAND17GEN1E LIFESCIENCES INC2DE LEEUW ERIK1SHAPIRO PAUL S1UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION1
Top patents by PatentIndex Score
23 records- 0196US11078171B2Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitorsUNIV MARYLAND·Filed 2020·Granted Aug 3, 2021·13 cites·13 claims
- 0294US11718595B2Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitorsUNIV MARYLAND·Filed 2021·Granted Aug 8, 2023·4 cites·19 claims
- 0390US9115122B2Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK)SHAPIRO PAUL S·Filed 2013·Granted Aug 25, 2015·9 cites·4 claims
- 0484US2025100985A1NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORSUNIV MARYLAND·Filed 2024·Application pending·0 cites
- 0582US12404259B2Inhibitors of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2024·Granted Sep 2, 2025·0 cites·12 claims
- 0681US12202810B2Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitorsUNIV MARYLAND·Filed 2023·Granted Jan 21, 2025·0 cites·18 claims
- 0777US2025353826A1Inhibitors of extracellular signal-regulated kinaseGEN1E LIFESCIENCES INC·Filed 2025·Application pending·0 cites
- 0870US8901164B2Amphipathic and other double-sided alpha-helix mimetics based on a 1,2-diphenylacetylene scaffoldUNIV MARYLAND·Filed 2014·Granted Dec 2, 2014·1 cites·11 claims
- 0963US2024140940A1Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective mcl-1 inhibitors and as dual mcl-1/bcl-2 inhibitorsUNIV MARYLAND·Filed 2023·Application pending·0 cites
- 1059US10941114B2Small molecule lipid II inhibitorsUNIV MARYLAND·Filed 2019·Granted Mar 9, 2021·0 cites·15 claims
- 1159US2023159569A1Dual hdac6/proteasome inhibitors, and methods of use thereofUNIV MARYLAND·Filed 2022·Application pending·0 cites
- 1259US2025120928A1Suberoylanilide hydroxamic acid (saha) drugs, conjugates, and nanoparticles, and methods of use thereofUNIV MARYLAND·Filed 2022·Application pending·0 cites
- 1358US9242944B2Potent analogues of the C-Myc inhibitor 10074-G5 with improved cell permeabilityUNIV MARYLAND·Filed 2014·Granted Jan 26, 2016·0 cites·11 claims
- 1456US2024293557A1Proteolysis targeting chimeras and methods of use thereofUNIV MARYLAND·Filed 2022·Application pending·0 cites
- 1556US2022396549A1Small molecule inhibitors of the mcl-1 oncoprotein and uses therofUNIV MARYLAND·Filed 2020·Application pending·0 cites
- 1656US2024299558A1Proteolysis targeting chimeras and polypharmacological agents targeting bcl-2, and methods of use thereofUNIV MARYLAND·Filed 2022·Application pending·0 cites
- 1753US2023140941A1Non-atp/catalytic site p38 mitogen activated protein kinase inhibitorsUNIV MARYLAND·Filed 2021·Application pending·0 cites
- 1852US11760752B2Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitorsUNIV MARYLAND·Filed 2020·Granted Sep 19, 2023·0 cites·15 claims
- 1945US10858316B2Small molecule inhibitors of the MCL-1 oncoprotein and uses thereofUNIV MARYLAND·Filed 2016·Granted Dec 8, 2020·0 cites·20 claims
- 2040US10961214B2Small molecule lipid II inhibitorsDE LEEUW ERIK·Filed 2016·Granted Mar 30, 2021·0 cites·22 claims
- 2139US10980811B2Reversal of fosfomycin resistanceUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2018·Granted Apr 20, 2021·0 cites·16 claims
- 2238US2004219202A1Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moietyFiled 2002·Application pending·0 cites
- 2337US11459313B2Aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid leukemiaUNIV MARYLAND·Filed 2017·Granted Oct 4, 2022·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Steven Fletcher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →